Exposure to excessive levels of manganese (Mn) 
Manganese (Mn) is a trace metal essential for normal development and various physiological functions (Aschner et al., 2006) . However, exposure to excessive levels of Mn results in the development of a Parkinson's disease (PD)-like disorder called manganism (Aschner et al., 2006) . Manganism patients suffer from multiple parkinsonian movement abnormalities including bradykinesia, tremors, rigidity, and postural dysfunction (Bowler et al., 2006) . In rodent and nonhuman primate models, Mn overexposure results in accumulation of Mn in brain regions including the basal ganglia, disruption of GABAergic and dopaminergic (DA) neurotransmission, activation of glial cells, and eventually neuronal loss (Burton and Guilarte, 2009) .
One potential mechanism underlying Mn neurotoxicity is the induction of reactive oxygen species (ROS) generation and subsequent oxidative damage to neurons. ROS may attack macromolecules in the affected neurons leading to functional impairment and structural damage (Harman, 1956) . In animals, administration of Mn results in elevated ROS generation and oxidative stress in various brain regions, especially in the globus pallidus, striatum, and substantia nigra (Ali et al., 1995; Dobson et al., 2003; Erikson et al., 2004) . Treatment with antioxidants, on the other hand, reduces the deleterious neurotoxic effects of Mn (Milatovic et al., 2007) .
In addition to inducing ROS generation inside affected neurons, Mn may induce free radical generation in glial cells, especially microglial cells. Microglia, as the resident immune cells in the brain, are particularly sensitive to homeostatic changes of the brain and readily become activated in response to a variety of environmental and toxic agents as well as neuronal injury (Liu, 2006) . Microglial activation has been increasingly associated with the pathogenesis of a number of neurodegenerative disorders including Alzheimer's disease and PD (Liu, 2006) . The distribution of microglia in the brain is heterogeneous, and the midbrain region where the basal ganglia reside is particularly enriched in microglia (Kim et al., 2000; Lawson et al., 1990) . Microglial activation in the substantia nigra has been reported in rats and nonhuman primates exposed to Mn (Verina et al., 2011; Zhao et al., 2009) . We have previously observed significant DA neurotoxicity in primary neuron-glia cultures following treatment with low micromolar concentrations of Mn 2+ (Zhang et al., 2009) , which were at the low end of the concentration range found in the brains of accidentally exposed humans and experimental animals (rodents and nonhuman primates; Erikson et al., 2004) . One of the major contributors to the observed Mn neurotoxicity is ROS production in Mn-activated microglia (Zhang et al., 2007 (Zhang et al., , 2009 ). However, the precise mechanism underlying Mn 2+ -induced microglial ROS generation remains undefined.
The mitochondrial electron transport chain (ETC) is the major intracellular site for ROS production. Under physiological conditions, the amount of ROS generated from the ETC is infinitesimal (St-Pierre et al., 2002) . However, under pathological conditions or in the presence of ETC inhibitors, ROS production is markedly elevated with complex I and III as the main sites of production (Muller et al., 2004) . Previous studies using rat brain homogenate, neuronal and astroglial cultures, have reported that Mn 2+ interferes with oxidative phosphorylation by inhibiting ETC complex activities or decreasing ATP production (Chen et al., 2001; Galvani et al., 1995; Gavin et al., 1999; Gunter et al., 2010; Milatovic et al., 2007; Zhang et al., 2004; Zwingmann et al., 2003) . However, in microglia, the involvement of specific mitochondrial ETC complexes in Mn 2+ -induced ROS generation has not been determined. In this study, we report that mitochondria are the main site of Mn 2+ -induced H 2 O 2 production in microglia and mitochondrial ETC complexes differentially contribute to this process.
MATERIALS AND METHODS
Reagents. Dulbecco's Modified Eagle's Medium (DMEM) was purchased from Mediatech (Manassas, VA). Heat-inactivated fetal bovine serum (FBS), Amplex UltraRed, 5-(and-6)-chloromethyl-2ʹ,7ʹ-dichlorodihydrofluorescein diacetate (CM-H 2 DCFDA), and horseradish peroxidase (HRP) were from Invitrogen (Carlsbad, CA). Phenol red-free Hank's balanced salt solution (HBSS) was from Hyclone (Logan, UT). Poly-D-lysine, manganese chloride, cupric sulfate, and sucrose were from Fisher Scientific (Fair Lawn, NJ). Cobalt chloride was from Merck (Whitehouse Station, NJ). H 2 O 2 (3%) and complete mini protease inhibitor tablets were from Cell Technology (Mountain View, CA) and Roche (Indianapolis, IN), respectively. Antibodies against lactate dehydrogenase (LDH), histone H1, cytochrome c oxidase subunit III (COX III), and cytochrome c were from Santa Cruz Biotechnology (Santa Cruz, CA). SuperSignal West Dura chemiluminescence reagent and micro bicinchoninic acid (BCA) protein assay reagent were from Pierce (Rockford, IL). Percoll was from GE Healthcare Sciences (Piscataway, NJ). All other reagents were from Sigma (St. Louis, MO).
Rat microglial cell culture. Highly aggressively proliferating immortalized (HAPI) microglial cells from rat (Cheepsunthorn et al., 2001) were cultured in DMEM containing 5% FBS, 50 U/ml penicillin, and 50 µg/ml streptomycin at 37°C in a humidified environment with 5% CO 2 and 95% air as previously described (Dutta et al., 2012; Zhang et al., 2007) . For treatment, HAPI cells were seeded at 1 × 10 5 /well in 96-well plates 1 day before treatment.
Rat primary mixed glia and astroglia cultures. Primary mixed glia and astroglia cultures were prepared from the brains of 1-day-old Fisher F344 rat pups following our previously described protocols (Zhang et al., 2007 (Zhang et al., , 2010 . For experiments, cultures were seeded in 96-well plates. All procedures involving animals were approved by University of Florida Institutional Animal Care and Use Committee.
Preparation of microglial mitochondrial, nuclear, and cytosolic fractions. A two-step procedure was used to obtain highly pure subcellular fractions from microglial cells. Crude subcellular fractions were prepared using differential centrifugation (Frezza et al., 2007) . Afterward, the crude mitochondrial, nuclear, and cytosolic fractions were further purified using Percoll gradient, sucrose cushion, and ultracentrifugation, respectively. To prepare the crude subcellular fractions, cells were seeded in 100-mm culture dishes and grown to confluence. All subsequent procedures were performed at 4°C. Cells were washed 3× with PBS and scraped into 350 µl/dish of isolation buffer (IB; 250mM sucrose, 10mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid [HEPES] , 1mM ethylene glycol tetraacetic acid [EGTA], 2mM PMSF, 0.1% bovine serum albumin [BSA] , and protease inhibitors, pH 7.4). Cells were homogenized with a Dounce homogenizer with tight pestle for 40 strokes and > 75% of the cells were disrupted (trypan blue exclusion). Cell homogenate was transferred into microcentrifuge tubes and centrifuged at 800 × g for 10 min. The supernatant was saved, and the pellet containing the nuclear fraction and unbroken cells was resuspended in IB and homogenized again for 10-20 strokes to achieve a disruption rate of > 90%. The homogenate was centrifuged again at 800 × g for 10 min. The pellet was saved as the crude nuclear fraction. The supernatant was pooled and centrifuged at 10,000 × g for 10 min. The resulting pellet was saved as the crude mitochondrial fraction and the supernatant as the crude cytosolic fraction. The mitochondrial pellet was further washed 2× in suspension buffer (SB; 250mM sucrose, 10mM HEPES, 0.1% BSA, pH 7.4) and centrifuged at 10,000 × g for 10 min. The final crude mitochondrial pellet was resuspended in SB.
Crude mitochondrial fraction was further purified using a discontinuous Percoll gradient (Leister and Herrmann, 2007) . The crude mitochondrial pellet was resuspended in 1 ml of ice cold 12% Percoll in IB and carefully layered on a discontinuous Percoll gradient of 20% (3 ml) and 40% (1 ml) in a 5 ml ultracentrifuge tube. Following centrifugation for 10 min at 30,000 × g, the mitochondrial fraction (a thin white band between the 20 and 40% Percoll) was carefully retrieved and diluted with eight volumes of IB. After two washes by centrifugation at 17,000 and 7,000 × g for 10 min each, the final pellet was resuspended in 100 µl of SB.
The crude nuclear fraction was further enriched using the sucrose cushion method (Cox and Emili, 2006) . Briefly, the crude nuclei pellet was resuspended in 4 ml of IB and carefully layered over a sucrose cushion (61% in IB, 1 ml). After centrifugation at 80,000 × g for 30 min, the nuclear pellet was resuspended in SB and washed 2× by centrifugation at 800 × g for 10 min. The final nuclear pellet was resuspended in 100 µl of SB.
The crude cytosolic fraction was centrifuged at 100,000 × g for 60 min, and the supernatant was saved as cytosol. Protein concentration was determined using the BCA reagents with BSA as standard, and the mitochondrial preparation was immediately used for assays. Aliquots were saved for Western blot analysis.
Mitochondrial respiration assay. Mitochondrial oxygen consumption was measured at room temperature using an YSI 5300 O 2 monitor (Yellow Spring Instrument, Yellow Springs, OH) coupled with a HP3395 integrator (Hewlett-Packard Company, Palo Alto, CA). Mitochondrial preparation (0.25 mg protein) was kept in a buffer consisting of 120mM KCl, 10mM HEPES, 2mM MgCl 2 , 2mM KH 2 PO 4 , and 0.1% BSA (pH 7.4, 1 ml). Uncoupled respiration was initiated by adding 5µM of carbonyl cyanide-4-(trifluoromethoxy)-phenylhydrazone (FCCP) in the presence of substrates (5mM glutamate plus 2.5mM malate plus 5mM succinate). To determine mitochondrial respiratory control ratio, ADP (50µM) was added to mitochondrial fraction that was respiring in the presence of substrates (5mM glutamate plus 2.5mM malate plus 5mM succinate). Respiratory control ratio was defined as the ratio of respiration rates observed in the presence and absence of ADP. To determine whether Mn 2+ had an effect on mitochondrial respiration, Mn 2+ was added before and after the addition of ADP to respiring mitochondrial fraction.
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Determination of H 2 O 2 concentrations. The amount of H 2 O 2 produced was determined using the fluorescent probe Amplex UltraRed in the presence of HRP as previously described (Zhang et al., 2007) . Briefly, cells in 96-well plates were washed 3× with HBSS and then treated with divalent metals in HBSS (100 µl/well). The amount of H 2 O 2 was determined in the presence of 50µM Amplex UltraRed and 1 U/ml HRP. Fluorescence intensities were measured at 530 nm (excitation) and 590 nm (emission) using a Synergy HT plate reader (Bio-Tek Instruments, Winooski, VT). The concentrations of H 2 O 2 in the samples were calculated based on a standard curve generated from known concentrations of H 2 O 2 standard run alongside the samples.
To determine the amounts of H 2 O 2 produced by microglial subcellular fractions, 10 µg of subcellular fractions were mixed with 50µM Amplex UltraRed and 1 U/ml HRP in an assay system containing 250mM sucrose, 10mM HEPES, 0.1% BSA (pH 7.4) in a final volume of 100 µl. The ETC inhibitors used were 10µM rotenone, 10µM antimycin A, 5mM malonate, 10µM thenoyltrifluoroacetone (TTFA), 1µM myxothiazol, 1mM azide, and 1µM oligomycin. Concentrations of the inhibitors were chosen to achieve a complete inhibition of specific electron transport sites in each complex (Barja and Herrero, 1998) . The respiratory substrates used were malate (2.5mM) and glutamate (5mM) for complex I and succinate (5mM) for complex II, respectively. Production of H 2 O 2 was initiated by the addition of substrates, and the fluorescence was monitored over a period of 30 min. The amounts of H 2 O 2 produced over the 30-min assay period were calculated against a standard curve established with known amounts of H 2 O 2 . To determine the magnitude of potential quenching by intact mitochondria of the fluorescent signal (St-Pierre et al., 2002) , a series of known concentrations of H 2 O 2 standard were assayed for fluorescent intensity in the standard Amplex UltraRed assay system described earlier with and without the inclusion of the mitochondrial fraction. As shown in Supplementary figure 1A , the presence of mitochondrial fraction exhibited a concentration-dependent quenching of the H 2 O 2 -generated fluorescent signal, whereas no quenching was observed for the nuclear and cytosolic fractions (data not shown). Therefore, the amounts of H 2 O 2 produced in the mitochondria-containing experiments were corrected for quenching based on standard curves with and without mitochondrial fraction (St-Pierre et al., 2002) . Time course studies showed biphasic increases in the fluorescent signal intensities with 30 min as a midpoint between the two phases (Supplementary fig. 1B ). Therefore, in subsequent studies with subcellular fractions, we determined the concentrations of H 2 O 2 at the 30 min time point.
Measurement of intracellular ROS production. The production of ROS was determined with CM-H 2 DCFDA as described (Zhang et al., 2009) . Briefly, cells in 96-well plates were treated with HBSS or divalent metals in HBSS (100 μl/well) for 6 h. At the end of treatment, cultures were rinsed 3× with warm HBSS and incubated for 1 h at 37°C with 5μM CM-H 2 DCFDA in HBSS. Fluorescence intensities were determined at 485 nm (excitation) and 530 nm (emission) using a Synergy HT plate reader.
Western blot analysis. To solubilize membrane proteins, mitochondrial and nuclear fractions were incubated with Triton-X-100 (0.5% final concentration in SB) for 30 min on ice. The mixture was then briefly sonicated and centrifuged for 20 min at 20,000 × g at 4°C. The supernatant was saved and assayed for protein concentration (Zhang et al., 2007) . Cytosolic and detergent-solubilized mitochondrial and nuclear fractions (50 µg) were separated on polyacrylamide gels and transferred to nitrocellulose membrane. Following blocking at room temperature for 1 h with blocking solution (5% nonfat milk in PBS-0.1% Tween-20 [T-PBS]), the blots were incubated overnight at 4°C with primary antibodies (all diluted 1:1000 in 3% BSA-T-PBS). Bound primary antibodies were detected by incubation with appropriate secondary antibodies in blocking solution for 1 h at room temperature. The membranes were developed using the SuperSignal West Dura chemiluminescent reagent and recorded with a BioRad ChemiDoc XRS digital imaging system and the Quantity One image analysis software.
Statistical analysis. Data were analyzed for significance by one-way analysis of variance followed by Fisher's LSD (Least Significant Difference) post hoc analysis using the JMP version 8 software (SAS Institute, Cary, NC). A p value of < 0.05 was considered statistically significant.
RESULTS

Effect of Divalent Cations on H 2 O 2 Production in Glial Cultures
To . Cells were treated for 6 h with 10µM of the indicated divalent metals or vehicle control (HBSS). Treatment with 10µM Mn 2+ for 6 h has been shown to be the optimal steady-state condition for Mn 2+ -stimulated H 2 O 2 production and release in HAPI cells in our previous study (Zhang et al., 2007) . As shown in Figure 1 fig. 2 ). In addition, cells treated with 100µM of the indicated metals exhibited a similar profile in H 2 O 2 production compared with cells treated with 10µM of the same metals (Supplementary fig. 3 ), similar to the lack of concentration dependence between 3 and 33µM Mn 2+ observed in our previous study (Zhang et al., 2007) .
In addition to HAPI microglial cells, we determined the effects of divalent metal ions on H 2 O 2 production in rat primary mixed glia (made up of 15% microglia and 85% astroglia) and rat primary astroglia. When mixed glia cultures were exposed to Mn 2+ (10µM, 6 h), production of H 2 O 2 was fivefold greater than that in the control (Fig. 1) . However, under the same conditions, other divalent metals tested were ineffective in inducing H 2 O 2 production. In primary astroglia, none of the divalent metals tested induced a significant H 2 O 2 production ( Fig. 1) , indicating that microglia, but not astroglia in mixed glia culture were the source of Mn 2+ -induced H 2 O 2 production. These results indicated that Mn 2+ , but not the other divalent metals tested, was capable of inducing H 2 O 2 production from microglia but not astroglia.
Mitochondria and Mn
2+ -Induced H 2 O 2 Production
To determine the subcellular compartment/organelle responsible for the Mn 2+ -stimulated H 2 O 2 production in microglia, we prepared mitochondrial, nuclear, and cytosolic fractions from HAPI microglial cells. As shown in Figure 2 , when mitochondrial respiratory substrates (5mM glutamate plus 2.5mM malate plus 5mM succinate) were present, 10µM Mn 2+ induced a significant H 2 O 2 production in the mitochondrial fraction, but not in the cytosolic or nuclear fractions (Fig. 2) under the same conditions. As positive controls, rotenone and antimycin A, known inhibitors of mitochondrial ETC complex I and III, respectively (St-Pierre et al., 2002) , induced robust H 2 O 2 production in mitochondria, but not in cytosol or nuclei (Fig. 2) .
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To confirm that the mitochondrial preparations isolated from microglia were functionally viable, we measured respiration rate using oxygen consumption assay. As shown in Figure 3A , addition of FCCP, an oxidative phosphorylation uncoupler, caused a sixfold increase in the respiration rate (Fig. 3A) . In addition, application of ADP to the respiring mitochondrial fraction resulted in a respiratory control ratio of 6 (Fig. 3B) . These results, together with the responses to ETC inhibitors (Fig. 2) demonstrated that the coupling between respiration and phosphorylation remained intact in our microglial mitochondrial fraction. The purity of subcellular fractions was assessed by immunoblot analysis for organelle-specific markers. As shown in Figure 3C , mitochondrial marker proteins cytochrome c and COX III were detected only in the mitochondrial, but not in the cytosolic and nuclear fractions. Similarly, LDH and histone H1 were detected only in the cytosolic and nuclear fractions, respectively (Fig. 3C) , indicating that the subcellular fractions were highly pure. Furthermore, the two-step preparation procedure achieved a 65-fold enrichment of mitochondrial fraction judged by the relative intensity of cytochrome c immunoreactivity between the mitochondrial fraction and that of total cellular homogenate (Fig. 3D) . in the control cultures of HAPI microglial cells, primary mixed glia, and primary astroglia were 0.15 ± 0.04, 0.16 ± 0.08, and 0.09 ± 0.07 (mean ± SEM), respectively. Results are mean ± SEM of three to four experiments. **p < 0.005 compared with the control.
FIG. 2. Effect of Mn
2+ on H 2 O 2 production in mitochondrial, cytosolic, and nuclear fractions of HAPI microglial cells. Subcellular fractions (10 µg protein) were incubated for 30 min at 37°C with 10µM of Mn 2+ , rotenone (rot), or antimycin A (AA) in the assay buffer. Substrates (5mM glutamate, 2.5mM malate, and 5mM succinate) were added to initiate the reaction and amount of H 2 O 2 produced was measured. Data are mean ± SEM of three to five experiments performed in duplicates. *p < 0.05 and **p < 0.005 compared with the control (no substrates).
FIG. 3. Analysis of mitochondrial functionality and purity. (A) and (B)
Mitochondrial respiration. Respiration was determined using a buffer containing mitochondrial fraction (250 µg protein) and respiration substrates (5mM glutamate plus 2.5mM malate plus 5mM succinate). (Fig. 4) . In contrast, the amount of H 2 O 2 produced by mitochondria respiring on succinate was considerably elevated compared with that on malate and glutamate, consistent with the notion that succinate drives ROS production from complex I by reverse electron transfer (Jeohn et al., 2002) . More importantly, this succinate-supported H 2 O 2 production was further elevated in the presence of 10 and 100µM Mn 2+ (Fig. 4) . As expected, rotenone induced significant H 2 O 2 production by mitochondria respiring on complex I substrates and antimycin A induced significant H 2 O 2 production in the presence of either substrates (Fig. 4) . Mn 2+ at 100µM induced a comparable amount of H 2 O 2 production in the presence of succinate as that induced by antimycin A (Fig. 4) . These data show that complex I substrates, glutamate and malate, supported minimal H 2 O 2 production by microglial mitochondria in the absence or presence of Mn
2+
. In contrast, the complex II substrate, succinate, afforded significant H 2 O 2 production and Mn 2+ further elevated H 2 O 2 production by microglial mitochondria (Fig. 4) .
The effect of Mn 2+ on complex II activity was investigated by respiration in the presence of succinate. As shown in Figure 5A , Mn 2+ at 10 and 100µM exerted minimal effects on mitochondrial O 2 consumption. At 800µM, Mn 2+ slightly enhanced mitochondrial O 2 consumption. Furthermore, Mn 2+ at 10, 100, and 800µM failed to alter mitochondrial state 3 respirations in the presence of ADP (Fig. 5B) . These results suggested that the increased H 2 O 2 production induced by Mn 2+ was not due to increased utilization of succinate.
Effect of ETC Complex Inhibitors on the Mn
2+ -Induced Mitochondrial H 2 O 2 Production
The observation that complex I and II substrates differentially supported Mn 2+ -induced H 2 O 2 production prompted us to further investigate the mechanism of Mn 2+ -induced ROS production by testing the effects of various electron transport inhibitors on Mn 2+ -induced H 2 O 2 production in the presence of either complex I or complex II substrates.
In the presence of succinate and complex III inhibitors antimycin A and myxothiazol, the amount H 2 O 2 produced by mitochondria was significantly increased (Fig. 6 ). In contrast, complex II inhibitor malonate decreased the succinatesupported H 2 O 2 production to baseline (Fig. 6) . Addition of Mn 2+ (10µM) to mitochondria respiring on succinate significantly increased the amount of H 2 O 2 produced (Fig. 6) . This succinate-supported and Mn
2+
-elevated H 2 O 2 production was significantly reduced only by cotreatment with malonate, but not rotenone, antimycin A, myxothiazol, azide, or oligomycin (Fig. 6) . These results indicated that the electrons that gave rise to superoxide production (and consequently H 2 O 2 production) in response to Mn 2+ treatment entered the ETC at complex II. Consistent with this notion, blockade of complex II activity by malonate abolished Mn 2+ -induced H 2 O 2 production (Fig. 6) .
FIG. 4. Substrate specificity for Mn
2+ -induced H 2 O 2 production from mitochondria. Mitochondrial fraction (10 μg protein) in the presence of either succinate (suc) or glutamate/malate (M/G) was incubated with 1, 10, or 100μM of Mn 2+ , 10μM rotenone (rot), or 10μM antimycin A (AA). H 2 O 2 production was then determined. Data are mean ± SEM of three to eight experiments performed in duplicate. *p < 0.05 and **p < 0.005 compared with control.
FIG. 5. Effect of Mn
2+ on mitochondrial complex II respiration. Mitochondrial respiration was initiated by the addition of succinate. Mn 2+ was then added followed by the addition of ADP (A) or vice versa (B). Mn 2+ was added at increasing concentrations. ADP was used to initiate state 3 respiration. 302 LIU ET AL.
Next, the effect of inhibitors and Mn 2+ on H 2 O 2 production in mitochondria driven by complex I substrates (malate and glutamate) was determined. The basal amount of H 2 O 2 produced by mitochondria respiring on malate and glutamate was very low (Fig. 7) . Moreover, Mn 2+ (10µM) did not increase baseline H 2 O 2 production (Fig. 7) . On the other hand, rotenone, antimycin A, and myxothiazol induced significant H 2 O 2 production (Fig. 7) . However, Mn 2+ (10µM) did not have any effect on the inhibitor-induced H 2 O 2 production (Fig. 7) . These results suggested that complex I was not a contributor to the Mn 2+ -induced H 2 O 2 production in microglial mitochondria.
To gain insight into the ROS-generating site in complex II responsible for the Mn 2+ -induced H 2 O 2 production, we tested the effect of three site-specific complex II inhibitors. Malonate and malate are analogues of succinate that inhibit complex II by binding to the flavin-binding site (site II F ). TTFA is a specific inhibitor of ubiquinone-binding site in complex II (site II Q ). As shown in Figure 8 , malonate and malate significantly decreased the Mn 2+ -induced H 2 O 2 production, whereas TTFA failed to prevent H 2 O 2 production induced by Mn
2+
. These results suggested that Mn 2+ -induced H 2 O 2 production was generated from site II F in complex II.
DIScUSSION
This study in rat microglia demonstrated that the mitochondrial ETC was the major intracellular site of Mn 2+ -induced H 2 O 2 production and that this effect was mediated principally through ETC complex II. This conclusion was supported by the following observations: (1) Mn 2+ induced a significant increase in H 2 O 2 production in the mitochondrial but not in the nuclear and cytosolic fractions; (2) the presence of complex II substrate (succinate), but not complex I substrates (malate and glutamate), was required for the Mn 2+ -induced H 2 O 2 production; and (3) complex II inhibitor (malonate and malate) inhibited the Mn 2+ -induced H 2 O 2 production by competing with succinate for the active sites on complex II.
Oxidative Stress Induced by Divalent Transition Cations
In this study, among the divalent metals tested, only Mn 2+ caused significant H 2 O 2 production in rat microglia ( Fig. 1) with Cu 2+ had a slight increase (p = 0.0935; n = 4). In hepatocytes, Cu 2+ and Cd 2+ have been reported to cause intracellular ROS
FIG. 6. Effect of the ETC inhibitors and Mn
2+ on H 2 O 2 production from mitochondria in the presence of complex II substrate. Mitochondrial fraction (10 µg protein) was incubated with 10µM of Mn 2+ and/or the indicated inhibitors. H 2 O 2 production was then determined. Data are mean ± SEM of three to five experiments performed in duplicate. *p < 0.05 and **p < 0.005 compared with control (mitochondria plus succinate); +p < 0.05 compared with 10µM Mn treatment.
FIG. 7. Effect of the ETC inhibitors and Mn
2+ on H 2 O 2 production from mitochondria in the presence of complex I substrates. This experiment was performed in the same manner as that described for Figure 6 except that malate and glutamate were used as substrates. Data are mean ± SEM of three to eight experiments performed in duplicate. *p < 0.05 compared with control (mitochondria plus malate + glutamate).
FIG. 8.
Effect of TTFA, malate, and malonate on the Mn 2+ -induced mitochondrial H 2 O 2 production in the presence of succinate. Mitochondrial fraction (10 µg protein) was incubated with 10µM Mn 2+ with and without TTFA (10µM), malate (2.5mM), or malonate (5mM). H 2 O 2 production was then determined. Results are expressed as a percentage of H 2 O 2 production in the presence of 5mM succinate. The levels of H 2 O 2 in the MnCl 2 -treated HAPI microglial cells were 2.18 ± 0.42µM (mean ± SEM). Results are mean ± SEM of three to four experiments. *p < 0.05 and **p < 0.005 compared with the control.
MITOCHONDRIAL COMPLEX II AND MANGANESE production, glutathione depletion, and cytotoxicity (Pourahmad and O'Brien, 2000) . We have also detected significant intracellular ROS production in HAPI microglia and mixed glia culture in response to treatment with 10µM of Mn fig. 4 ). It remains to be determined why Cu 2+ and Fe 2+ treatments do not cause increased production of H 2 O 2 from rat microglia. One possibility could be related to the activity of mitochondrial enzyme Mn-superoxide dismutase (Mn-SOD). Mn-SOD activity has been shown to be elevated by the exogenously added Mn 2+ (Culotta et al., 2006) . Fe 2+ has been demonstrated to substitute Mn 2+ in the Mn-SOD, leaving the enzyme in an inactivated form (Whittaker, 2003) , which could result in a much subdued dismutation of intracellular superoxide to H 2 O 2 .
Relative Contribution of Microglia and Astroglia to Mn
In the context of metal-induced neurotoxicity, astroglia are believed to be the storage site for metals in the CNS (TiffanyCastiglion and Qian, 2001) . Previous studies have reported increased intracellular superoxide production in astroglia induced by Mn 2+ (Liao et al., 2007) , in agreement with our results on intracellular ROS production in Mn 2+ -treated astroglia. However, little H 2 O 2 was produced and released by astroglia following Mn 2+ treatment (Fig. 1 ). This may be explained by the high concentration of antioxidants such as glutathione found in astroglia compared with neurons and microglia (Knott et al., 1999; Teismann and Schulz, 2004 ) that may readily neutralize intracellular ROS leaving little for conversion into H 2 O 2 and release into the extracellular space to harm vulnerable bystanding neurons.
Mitochondria As the Subcellular Site of Mn
2+ -Induced ROS Generation in Microglia
In this study, Mn 2+ promoted H 2 O 2 production in microglial mitochondria, but not in cytosol or nuclei (Figs. 1 and  4) . Previous reports have suggested that Mn 2+ can interfere with the mitochondrial oxidative phosphorylation, respiration, and ATP production (Chen et al., 2001; Galvani et al., 1995; Gavin et al., 1999; Gunter et al., 2010; Milatovic et al., 2007; Zwingmann et al., 2003) . In addition, Mn 2+ has been reported to preferentially accumulate in either mitochondria (Gunter et al., 2009) or nuclei in astroglia and neurons (Kalia et al., 2008; Morello et al., 2008) . Although the subcellular distribution of Mn 2+ in microglia remains to be determined, our results suggest that the accumulation of Mn 2+ in the mitochondria may be more directly related to the enhanced H 2 O 2 production in microglia.
Involvement of ETC Complexes in Mn
2+ -Induced H 2 O 2 Production in Microglia
Complex III inhibitors antimycin A and myxothiazol are known to induce H 2 O 2 production (St-Pierre et al., 2002) . Antimycin A and myxothiazol inhibit the center i and Rieske iron-sulfur center of complex III, respectively (St-Pierre et al., 2002) . The inhibition afforded by antimycin A facilitates the formation of semi-ubiquinone radical, which is highly unstable and readily gives rise to superoxide formation at complex III center o (St-Pierre et al., 2002) . In this study, in the presence of complex I substrates, rotenone and antimycin A caused significant H 2 O 2 production (Fig. 7) . Myxothiazol increased H 2 O 2 production to a similar level as that of rotenone, suggesting that H 2 O 2 produced by myxothiazol was most probably generated at the same site as that for rotenone at complex I. In the presence of succinate, antimycin A produced the highest amount of H 2 O 2 . This result is in agreement with a previous study, which reported that in the presence of antimycin A, complex III plays the central role in mitochondrial H 2 O 2 production (Chen et al., 2003) .
In this study, in the presence of complex I substrates, Mn 2+ at 10 or 100µM failed to induce H 2 O 2 production in mitochondria (Fig. 4) . This result suggests that complex I is not the site of Mn
2+
-induced ROS production in forward electron transport from complex I toward downstream complexes in the ETC. On the other hand, in the presence of complex II substrate succinate, Mn 2+ at the same concentration induced considerable H 2 O 2 production (Fig. 4) . Addition of rotenone was not able to inhibit this effect, demonstrating that Mn 2+ -induced H 2 O 2 production was not through reverse electron transfer from complex II back to complex I. Notably, complex II inhibitor malonate was the only inhibitor that decreased the Mn 2+ -induced H 2 O 2 production supported by succinate (Fig. 6) . The respiration data suggest that Mn 2+ -induced H 2 O 2 production was not due to increased electrons influx from complex II (Fig. 5) .
Complex II in Mn
2+ -Induced H 2 O 2 Production
Mitochondrial complex II (succinate dehydrogenase [SDH] ) catalyzes the oxidation of succinate to fumarate with the reduction of ubiquinone to ubiquinol. The enzyme is composed of four subunits: A, B, C, and D. SDHA contains a flavin-binding site (site II F ) and SDHB has three iron-sulfur clusters. SDHC and SDHD are hydrophobic and serve to anchor SDH to the mitochondrial inner membrane. Complex II was not usually considered to be a major producer of ROS. However, a recent study (Quinlan et al., 2012) demonstrated that complex II can be an important source of ROS production both during forward and reverse electron transfer. This finding seems to corroborate well with our results that complex II plays a key role in the Mn 2+ -induced H 2 O 2 production. The precise mechanism governing how Mn 2+ interacts with complex II to cause increased ROS production remains to be determined. However, earlier studies have reported that mutations in SDHC and cytochrome b in complex II produce significantly elevated amount of superoxide (Ishii et al., 2005; Slane et al., 2006) . In addition, Mn 2+ has been shown to have an inhibitory effect on mitochondrial iron-sulfur-containing enzyme, and this effect is most likely due to the competition of Mn 2+ with Fe 2+ for the Fe 2+ -binding sites (Chen et al., 2001) . We speculate that Mn 2+ may destabilize iron-sulfur clusters containing SDHB to cause a configuration change of SDH, which has been shown to give rise to ROS formation (Lemarie et al., 2011) .
304
Previous studies have proposed that Mn 2+ could interact with each one of the complexes of the ETC to induce ROS formation (Chen et al., 2001; Galvani et al., 1995; Gavin et al., 1999; Malecki, 2001; Zhang et al., 2004) . These observations might have been complicated by different methodologies and systems employed. First, most of the studies have used a wide range of Mn 2+ concentrations of 5-1000µM in different systems (neuron, astroglia, brain homogenate). Second, those studies have measured ETC complex activity instead of ROS production. Our study was aimed at investigating the involvement of microglial mitochondrial ETC in ROS production induced by low micromolar concentration of Mn 2+ that may be relevant to elevated environmental exposure to Mn (Chen and Liao, 2002; Chen et al., 2001; Milatovic et al., 2007; Zhang et al., 2004; Zwingmann et al., 2003) . In healthy individuals, physiological concentrations of Mn in the plasma have been reported to be in the submicromolar range (Zheng et al., 1998) . In the brains of accidentally exposed humans and experimental animals (rodents and nonhuman primates), concentrations of Mn in the range of 4.4-334µM have been reported (Erikson et al., 2004) . In this study, we have shown that Mn 2+ at 10µM caused significant ROS generation in isolated mitochondria as well as intact microglial cells (Figs. 1 and 2 and Supplementary fig. 3 ). These results are consistent with our previous reports where Mn 2+ at 3-30µM was effective in the induction of microglial activation and preferential DA neurotoxicity in primary midbrain neuron-glia cultures (Zhang et al., 2007 (Zhang et al., , 2009 (Zhang et al., , 2010 . Mn 2+ concentrations in the range of 100-1000µM used in this and our previous studies were intended to be used as an upper limit of a dose range and unlikely to be relevant to the concentrations that may be related to chronic Mn toxicity.
Interaction of microglia with Mn in relation to ROS production has potentially important implications for Mn neurotoxicity. In the brain, the region-specific distribution of microglia is heterogeneous with midbrain area with potentially the highest abundance of microglia (Kim et al., 2000; Lawson et al., 1990) . This might suggest that neurons in the midbrain may be particularly vulnerable to Mn-induced microglial release of toxic factors. In PD, loss of DA-releasing neurons in the nigrostriatal DA pathway is the pathological hallmark (Liu, 2006) . On the other hand, in manganism, degeneration of GABAergic neurons in the globus pallidus is most prominent (Aschner et al., 2009; Burton and Guilarte, 2009) . It is possible that in addition to the abundance of microglia, differences in the ability of different brain regions to uptake, store, and/or sequester Mn will also play an important role in determining the site of damage for Mn neurotoxicity.
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